Roche plans Phase 3 for its lat­est Alzheimer’s drug at­tempt af­ter un­veil­ing more ear­ly da­ta

Roche on Thurs­day shared ear­ly pos­i­tive re­sults for its Alzheimer’s can­di­date tron­tinemab, the lat­est round of da­ta in its sec­ond at­tempt to de­vel­op a drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER